These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16309334)

  • 41. Illicit financial flows and the provision of child and maternal health services in low- and middle-income countries.
    Ortega B; Sanjuán J; Casquero A
    BMC Int Health Hum Rights; 2020 Jul; 20(1):15. PubMed ID: 32653039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ENHANCED IMMUNIZATION COVERAGE THROUGH INTERVENTIONS FOR CHILDHOOD CLUSTER DISEASES IN DEVELOPING COUNTRIES.
    Mureed S; Somronghtong R; Kumar R; Ghaffar A; Chapman RS
    J Ayub Med Coll Abbottabad; 2015; 27(1):223-7. PubMed ID: 26182782
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of four contingent valuation methods to estimate the economic value of a pneumococcal vaccine in Bangladesh.
    Heinzen RR; Bridges JF
    Int J Technol Assess Health Care; 2008; 24(4):481-7. PubMed ID: 18828944
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contingent Valuation Analysis of an Otolaryngology and Ophthalmology Emergency Department: The Value of Acute Specialty Care.
    Naunheim MR; Kozin ED; Sethi RK; Ota HG; Gray ST; Shrime MG
    JAMA Otolaryngol Head Neck Surg; 2017 Mar; 143(3):234-238. PubMed ID: 27893070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Contingent valuation for health care services. Review of domestic studies and outline of foreign investigations].
    Yasunaga H; Ide H; Imamura T; Ohe K
    Nihon Koshu Eisei Zasshi; 2006 Nov; 53(11):818-30. PubMed ID: 17228751
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The reliability and validity of willingness to pay surveys for reproductive health pricing decisions in developing countries.
    Foreit JR; Foreit KG
    Health Policy; 2003 Jan; 63(1):37-47. PubMed ID: 12468116
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Health care incentives in immunisation.
    Achat H; McIntyre P; Burgess M
    Aust N Z J Public Health; 1999 Jun; 23(3):285-8. PubMed ID: 10388173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacoeconomics of immunisation: a review.
    van den Oever R; de Graeve D; Hepp B; Stroobant A; Walckiers D; Van Casteren V; Van Loock F; Ducoffre G; Dewatripont J; Jacques P
    Pharmacoeconomics; 1993 Apr; 3(4):286-308. PubMed ID: 10146992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effective interventions to increase routine childhood immunization coverage in low socioeconomic status communities in developed countries: A systematic review and critical appraisal of peer-reviewed literature.
    Machado AA; Edwards SA; Mueller M; Saini V
    Vaccine; 2021 May; 39(22):2938-2964. PubMed ID: 33933317
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Economic analyses of rubella and rubella vaccines: a global review.
    Hinman AR; Irons B; Lewis M; Kandola K
    Bull World Health Organ; 2002; 80(4):264-70. PubMed ID: 12075361
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Do existing research summaries on health systems match immunisation managers' needs in middle- and low-income countries? Analysis of GAVI health systems strengthening support.
    Bosch-Capblanch X; Kelly M; Garner P
    BMC Public Health; 2011 Jun; 11():449. PubMed ID: 21651793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The contingent valuation method--appraising the appraisers.
    Johannesson M
    Health Econ; 1993 Dec; 2(4):357-9; discussion 363-5. PubMed ID: 8142997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contingent valuation: what needs to be done?
    Smith RD; Sach TH
    Health Econ Policy Law; 2010 Jan; 5(Pt 1):91-111. PubMed ID: 19706221
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of Missing Values and Protest Zeros in Contingent Valuation in Dental Medicine.
    Sendi P; Ramadani A; Bornstein MM
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299670
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estimating the welfare loss to households from natural disasters in developing countries: a contingent valuation study of flooding in Vietnam.
    Navrud S; Tuan TH; Tinh BD
    Glob Health Action; 2012; 5():17609. PubMed ID: 22761603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Private demand for a HIV/AIDS vaccine: evidence from Guadalajara, Mexico.
    Whittington D; Matsui-Santana O; Freiberger JJ; Van Houtven G; Pattanayak S
    Vaccine; 2002 Jun; 20(19-20):2585-91. PubMed ID: 12057616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The costs, effects and cost-effectiveness of strategies to increase coverage of routine immunizations in low- and middle-income countries: systematic review of the grey literature.
    Batt K; Fox-Rushby JA; Castillo-Riquelme M
    Bull World Health Organ; 2004 Sep; 82(9):689-96. PubMed ID: 15628207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What We Do Not Know About the Costs of Immunization Programs in Low- and Middle-Income Countries.
    Portnoy A; Resch SC; Suharlim C; Brenzel L; Menzies NA
    Value Health; 2021 Jan; 24(1):67-69. PubMed ID: 33431155
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Health system cost of delivering routine vaccination in low- and lower-middle income countries: what is needed over the next decade?
    Lydon P; Gandhi G; Vandelaer J; Okwo-Bele JM
    Bull World Health Organ; 2014 May; 92(5):382-4. PubMed ID: 24839329
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.